Brian Hom

CONFLICT OF INTEREST STATEMENT AA served on the speaker bureau for Johnson & Johnson. IS served on the advisory board for Recordati Rare Diseases. GY served on the advisory board for Abbvie, Daiichi, and Astazeneca; served on the speaker bureau for GSK, Rigel, Servier, Jazz, Bristol Myers Squibb, Kite, SOBI, Incyte, Secura Bio, Astellas, Blueprint, and Stemline therapeutics. Supporting Information Filename Description bjh19771-sup-0001-Supinfo.docxWord 2007 document , 598.5 KB Data S1.

Abstract : The use of stimulation of peripheral nerves to test or treat various medical disorders has been prevalent for a long time. Over the last few years, there has been growing evidence for the use of peripheral nerve stimulation (PNS) for treating a myriad of chronic pain conditions such as limb mononeuropathies, nerve entrapments, peripheral nerve injuries, phantom limb pain, complex regional pain syndrome, back pain, and even fibromyalgia.

In 1920, Ed Rice Sr. purchased Springfield’s Electric Bottling Co. The main products were seltzer water and Farmer Beverages, a line of mainly fruit-flavored soft drinks. The associated franchise rights to sell the Coca-Cola brand – newly listed on the New York Stock Exchange – represented only a small portion of Electric’s overall business. Nearly a century later, Ozarks Coca-Cola/Dr Pepper Bottling Co. is focused on little else.